Feasibility and safety of minimally invasive R1 vascular surgery for hepatocellular carcinoma: a cohort study

• Conditions: C22; Malignant neoplasm of liver and intrahepatic bile ducts

• Registration Number: DRKS00034789
• Lead Sponsor: Chirurgische Klinik, Universitätsmedizin Mannheim

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2024-07-15
• Study Start: 2024-07-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

Patients were eligible for inclusion if they were aged 18 years or older, underwent a curative, minimally invasive parenchymal-sparing hepatectomy for HCC, and had adequate preoperative imaging, including contrast-enhanced computed tomography (CT) and/or magnetic resonance imaging (MRI).

Exclusion Criteria

Missing preoperative imaging
non curative resections

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Postoperative complications, stratified according to the Clavien-Dindo (CD) classification

Secondary Outcome Measures

Name	Time	Method
- Operative characteristics (lenght of operation, extent of resection, blood loss, previous hepatic resection)<br>- Postoperative parameters (lenght of stay, postoperative intervention, postoperative mortality)